Global Blood Glucose Monitoring Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Blood Glucose Monitoring Market Research Report 2024
One of the main aims of diabetes treatment is to keep blood glucose levels within a specified target range. The key is balancing your food with your activity, lifestyle and diabetes medicines. Blood glucose monitoring can help you understand the link between blood glucose, food, exercise and insulin.
According to MRAResearch’s new survey, global Blood Glucose Monitoring market is projected to reach US$ 10610 million in 2033, increasing from US$ 7877 million in 2022, with the CAGR of 3.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Blood Glucose Monitoring market research.
Key companies engaged in the Blood Glucose Monitoring industry include Abbott Laboratories, ARKRAY, Inc., Bayer AG, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Medtronic plc, Nipro Diagnostics, Inc. and Terumo Medical Corporation, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Blood Glucose Monitoring were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Blood Glucose Monitoring market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Blood Glucose Monitoring market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Abbott Laboratories
ARKRAY, Inc.
Bayer AG
Dexcom, Inc.
F. Hoffmann-La Roche Ltd
Johnson & Johnson
Medtronic plc
Nipro Diagnostics, Inc.
Terumo Medical Corporation
Segment by Type
Single Point Blood Glucose Meters
Continuous Glucose Monitoring Systems
Hospitals Diagnostic Centers
Home Settings
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Blood Glucose Monitoring report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Blood Glucose Monitoring market is projected to reach US$ 10610 million in 2033, increasing from US$ 7877 million in 2022, with the CAGR of 3.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Blood Glucose Monitoring market research.
Key companies engaged in the Blood Glucose Monitoring industry include Abbott Laboratories, ARKRAY, Inc., Bayer AG, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Medtronic plc, Nipro Diagnostics, Inc. and Terumo Medical Corporation, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Blood Glucose Monitoring were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Blood Glucose Monitoring market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Blood Glucose Monitoring market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott Laboratories
ARKRAY, Inc.
Bayer AG
Dexcom, Inc.
F. Hoffmann-La Roche Ltd
Johnson & Johnson
Medtronic plc
Nipro Diagnostics, Inc.
Terumo Medical Corporation
Segment by Type
Single Point Blood Glucose Meters
Continuous Glucose Monitoring Systems
Segment by Application
Hospitals Diagnostic Centers
Home Settings
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Blood Glucose Monitoring report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source